Tehran (IP) – The deputy head of Razi Vaccine and Serum Research Institute announced the progress in the production of the Iranian vaccine 'Razi Cov Pars,' saying that the second dose of this vaccine will be given to all volunteers in the next few days.

Iran PressIran News: Mohammad-Hassan Fallah-Mehrabadi said on Thursday that the process of production and human trials of the Iranian COVID vaccine 'Razi Cov Pars' had been going well.

He noted that the necessary plans had been made to make this Iranian product available to the public in the shortest possible time.

The clinical trial of the 'Razi Cov Pars' vaccine, which is the first injectable-inhaled vaccine of recombinant protein in the world, began on two volunteers on February 28 in the presence of a group of officials and researchers at Rasoul Akram Hospital in Tehran.


Read more:

Iran's Razi Cov Pars vaccine, 1st inhaled vaccine in world

Volunteers get 'Razi Cov Pars' intranasal spray